View Item 

Show simple item record

Baseline Albumin Is Associated with Worsening Renal Function in Patients with Acute Decompensated Heart Failure Receiving Continuous Infusion Loop Diuretics
dc.contributor.authorClarke, Megan M.en_US
dc.contributor.authorDorsch, Michael P.en_US
dc.contributor.authorKim, Susieen_US
dc.contributor.authorAaronson, Keith D.en_US
dc.contributor.authorKoelling, Todd M.en_US
dc.contributor.authorBleske, Barry E.en_US
dc.date.accessioned2013-06-18T18:33:01Z
dc.date.available2014-08-01T19:11:33Zen_US
dc.date.issued2013-06en_US
dc.identifier.citationClarke, Megan M.; Dorsch, Michael P.; Kim, Susie; Aaronson, Keith D.; Koelling, Todd M.; Bleske, Barry E. (2013). "Baseline Albumin Is Associated with Worsening Renal Function in Patients with Acute Decompensated Heart Failure Receiving Continuous Infusion Loop Diuretics." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 33(6): 583-588. <http://hdl.handle.net/2027.42/98312>en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/98312
dc.publisherMcGraw‐Hillen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherRenal Functionen_US
dc.subject.otherAlbuminen_US
dc.subject.otherHeart Failureen_US
dc.subject.otherFurosemideen_US
dc.subject.otherBumetanideen_US
dc.titleBaseline Albumin Is Associated with Worsening Renal Function in Patients with Acute Decompensated Heart Failure Receiving Continuous Infusion Loop Diureticsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23553379en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/98312/1/phar1241.pdf
dc.identifier.doi10.1002/phar.1241en_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceKrumholz HM, Chen Y, Vaccarino V, et al. Correlates and impact on outcomes of worsening renal function in patients ≥65 years of age with heart failure. Am J Cardiol 2000; 85: 1110 – 3.en_US
dc.identifier.citedreferenceCowie MR, Komajda M, Murray‐Thomas T, Underwood J, Ticho B. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 2006; 27: 1216 – 22.en_US
dc.identifier.citedreferenceGheorghiade M, Konstam MA, Burnett JC, et al. Short‐term clinical effects of tolvaptan an oral vasopressin antagonist, in patients hospitalized for heart failure. The Everest Clinical Status Trial. JAMA 2007; 297: 1332 – 43.en_US
dc.identifier.citedreferenceCostanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675 – 83.en_US
dc.identifier.citedreferenceGheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol 2009; 53: 557 – 73.en_US
dc.identifier.citedreferenceMetra M, Davison B, Bettari L, et al. Is worsening renal function an ominous prognostic sign in patients with acute heart failure?: The role of congestion and its interaction with renal function. Circ Heart Fail 2012; 5: 54 – 62.en_US
dc.identifier.citedreferenceYanagisawa S, Miki K, Yasuda N, Hirai T, Suzuki N, Tanaka T. Clinical outcomes and prognostic factor for acute heart failure in nonagerians: impact of hypoalbuminemia on mortality. Int J Cardiol 2010; 145: 574 – 6.en_US
dc.identifier.citedreferenceUthamalingam S, Kandala J, Daley M, et al. Serum albumin and mortality in acutely decompensated heart failure. Am Heart J 2010; 160: 1149 – 53.en_US
dc.identifier.citedreferenceVander A, Sherman J, Luciano D. Circulation. In: Vander A., Sherman J., Luciano D, eds. Human Physiology. The Mechanisms of Body Function. New York, NY: McGraw‐Hill, 1980: 253 – 326.en_US
dc.identifier.citedreferenceQuinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005; 41: 1211 – 9.en_US
dc.identifier.citedreferenceArques S, Ambrosi P. Human serum albumin in the clinical syndrome of heart failure. J Card Fail 2011; 17: 451 – 8.en_US
dc.identifier.citedreferenceTestani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010; 122: 265 – 72.en_US
dc.identifier.citedreferenceNohria A, Hasselblad V, Stebbins A, et al. Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 2008; 51: 1268 – 74.en_US
dc.identifier.citedreferenceGottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002; 8: 136 – 41.en_US
dc.identifier.citedreferencePacker M. Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting‐enzyme inhibition. Eur Heart J 1990; 11 Suppl D: 44 – 52.en_US
dc.identifier.citedreferenceDamman K, Jaarsma T, Voors AA, et al. Both in‐ and out‐hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail 2009; 11: 847 – 54.en_US
dc.identifier.citedreferenceMetra M, Nodari S, Parrinello G, et al. Worsening renal function in patients hospitalized for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 2008; 10: 188 – 95.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
phar1241.pdf
Size:
68.99KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.